Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
An anomaly has been identified with the ct localization module of the fastplan treatment planning system. if the module reports a significant different in tilt or spin on a slice (compared to the average of all slices) and the user elects to "discard" that slice an incorrect calculation of the isocenter location may result. the calculated ct localization volume can be incorrect when the "discard option is selected after a detection of a significant difference in tilt or spin for a particular slice. if this issue goes undetected the reported coordinates of the isocenter will be incorrect and a mistreatment could result.